Aller au contenu

Publications scientifiques

  • article Goldstein I, Bélanger A, Cusan L, Archer D, Nappi RE, Portman D, Gudeman J

    In Memoriam: Fernand Labrie, June 28, 1937 – January 16, 2019

    Sex Med Rev 7 (2), 2019.

    DOI
  • article Ke Y, Simard JN, Gonthier R, Martel C, Vaillancourt M, Portman D, Belanger A, Labrie F

    In Reply

    Menopause 25 (8), 2018.

  • article Ke Y, Belanger A, Simard JN, Gonthier R, Martel C, Vaillancourt M, Labrie F

    Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy

    Menopause 25 (3), 2018.

  • article Belanger A, Utian W

    To the Editor

    Menopause 24 (8), 2017.

  • article Labrie F, Belanger A, Pelletier G, Martel C, Archer DF, Utian WH

    Science of intracrinology in postmenopausal women

    Menopause 24 (6), 2017.

  • article Labrie F, Martel C, Belanger A, Pelletier G

    Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology

    J Steroid Biochem Mol Biol 168 2017.

  • article Labrie F, Ke Y, Gonthier R, Belanger A

    Reprint of « Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays? »

    J Steroid Biochem Mol Biol 153 2015.

  • article Gauthier-Landry L, Belanger A, Barbier O

    Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution

    J Steroid Biochem Mol Biol 145 2015.

  • article Labrie F, Ke Y, Gonthier R, Belanger A

    Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays?

    J Steroid Biochem Mol Biol 149 2015.

  • article Ekstrom L, Cevenini L, Michelini E, Schulze J, Thorngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A

    Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes

    Eur J Clin Invest 43 (3), 2013.

  • article Grosse L, Paquet S, Caron P, Fazli L, Rennie PS, Belanger A, Barbier O

    Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications

    Cancer Res 73 (23), 2013.

  • article Paquet S, Fazli L, Grosse L, Verreault M, Tetu B, Rennie PS, Belanger A, Barbier O

    Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression

    J Clin Endocrinol Metab 97 (3), 2012.